The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
Open accessAbstract
OBJECTIVE—The aims of this study were to determine the incidence of diabetes among HIV-infected patients in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) cohort, to identify demographic, HIV-related, and combination antiretroviral therapy (cART)-related factors associated with the onset of diabetes, and to identify possible mechanisms for any relationships found. RESEARCH DESIGN AND METHODS—D:A:D is a prospective observational study of 33,389 HIV-infected patients; diabetes is a study end point. Poisson regression models were used to assess the relation between diabetes and exposure to cART after adjusting for known risk factors for diabetes, CD4 count, lipids, and lipodystrophy. RESULTS—Over 130,151 person-years of follow-up (PYFU), diabetes was diagnosed in 744 patients (incidence rate of 5.72 per 1,000 PYFU [95% CI 5.31–6.13]). The incidence of diabetes increased with cumulative exposure to cART, an association that remained significant after adjustment for potential risk factors for diabetes. The strongest relationship with diabetes was exposure to stavudine; exposures to zidovudine and didanosine were also associated with an increased risk of diabetes. Time-updated measurements of total cholesterol, HDL cholesterol, and triglycerides were all associated with diabetes. Adjusting for each of these variables separately reduced the relationship between cART and diabetes slightly. Although lipodystrophy was significantly associated with diabetes, adjustment for this did not modify the relationship between cART and diabetes. CONCLUSION—Stavudine and zidovudine are significantly associated with diabetes after adjustment for risk factors for diabetes and lipids. Adjustment for lipodystrophy did not modify the relationship, suggesting that the two thymidine analogs probably directly contribute to insulin resistance, potentially through mitochondrial toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Brown, T. T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1179 · Cited by 851
Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., Lo, J. C., & Schambelan, M. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00005 · Cited by 518
Behrens, G., Dejam, A., Schmidt, H., Balks, H.-J., Brabant, G., Körner, T., Stoll, M., & Schmidt, R. E. (1999) · AIDS · doi:10.1097/00002030-199907090-00001 · Cited by 515
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine
Martínez, E., Conget, I., Lozano, L., Casamitjana, R., & Gatell, J. M. (1999) · AIDS · doi:10.1097/00002030-199905070-00009 · Cited by 321
The U.K. Prospective Diabetes Study. A review
Turner, R. C. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.c35 · Cited by 267
Ledergerber, B., Furrer, H., Rickenbach, M., Lehmann, R., Elzi, L., Hirschel, B., Cavassini, M., Bernasconi, E., Schmid, P., Egger, M., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518619 · Cited by 261
Self-citationMynarcik, D. C., McNurlan, M. A., Steigbigel, R. T., Fuhrer, J., & Gelato, M. C. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200012010-00004 · Cited by 239
Sutinen, J., Häkkinen, A.-M., Westerbacka, J., Seppälä-Lindroos, A., Vehkavaara, S., Halavaara, J., Järvinen, A., Ristola, M., & Yki-Järvinen, H. (2002) · AIDS · doi:10.1097/00002030-200211080-00011 · Cited by 184
Tien, P. C., Schneider, M. F., Cole, S. R., Levine, A. M., Cohen, M., DeHovitz, J., Young, M., & Justman, J. E. (2007) · AIDS · doi:10.1097/qad.0b013e32827038d0 · Cited by 183
Fleischman, A., Johnsen, S., Systrom, D. M., Hrovat, M., Farrar, C. T., Frontera, W., Fitch, K., Thomas, B. J., Torriani, M., Côté, H. C. F., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00550.2006 · Cited by 160
Hadigan, C., Borgonha, S., Rabe, J., Young, V., & Grinspoon, S. (2002) · Metabolism · doi:10.1053/meta.2002.34704 · Cited by 158
Gan, S. K., Samaras, K., Thompson, C. H., Kraegen, E. W., Carr, A. D., Cooper, D. A., & Chisholm, D. J. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3163 · Cited by 149
van der Valk, M., Bisschop, P. H. L. T., Romijn, J. A., Ackermans, M. T., Lange, J. M. A., Endert, E., Reiss, P., & Sauerwein, H. P. (2001) · AIDS · doi:10.1097/00002030-200111090-00004 · Cited by 126
Self-citationShlay, J. C., Visnegarwala, F., Bartsch, G. E., Wang, J., Peng, G., El‐Sadr, W., Gibert, C. L., Kotler, D. P., Grünfeld, C., & Raghavan, S. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000143599.64234.15 · Cited by 100
Self-citationMeininger, G. E., Hadigan, C. M., Laposata, M., Brown, J., Rabe, J., Louca, J., Aliabadi, N., & Grinspoon, S. K. (2002) · Metabolism · doi:10.1053/meta.2002.29999 · Cited by 80
Walli, R., Michl, G. M., Bogner, J. R., & Goebel, F.-D. (2001) · PubMed · Cited by 53
Cited by
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Self-citationHammer, S. M., Eron, J. J., Reiss, P., Schooley, R. T., Thompson, M. A., Walmsley, S., Cahn, P., Fischl, M. A., Gatell, J. M., Hirsch, M. S., et al. (2008) · JAMA · doi:10.1001/jama.300.5.555 · Cited by 1,026
Self-citationInsulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929
Diabetes in sub-Saharan Africa
Mbanya, J. C. N., Motala, A. A., Sobngwi, E., Assah, F. K., & Enoru, S. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60550-8 · Cited by 775
Metadata
- Authors
- De Wit, S., Sabin, C. A., Weber, R., Worm, S. W., Reiss, P., Cazanave, C., El-Sadr, W., Monforte, A. D., Fontas, E., Law, M. G., Friis-Møller, N., & Phillips, A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 31
- Issue
- 6
- Pages
- 1224-1229
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2110717475
- Cited by
- 482
- References
- 21
- FWCI
- 33.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.